Published in J Clin Lab Anal on January 01, 2008
Evolution of organic aerosols in the atmosphere. Science (2009) 4.82
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet (2002) 4.47
Fatal outcome in two girls with hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy. Med Pediatr Oncol (2000) 2.02
Size matters more than chemistry for cloud-nucleating ability of aerosol particles. Science (2006) 1.96
Rainforest aerosols as biogenic nuclei of clouds and precipitation in the Amazon. Science (2010) 1.86
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol (1998) 1.79
Global air pollution crossroads over the Mediterranean. Science (2002) 1.68
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol (2003) 1.67
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) (2006) 1.63
Atopy and malaria. Wien Klin Wochenschr (2001) 1.48
The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol (2001) 1.47
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect (2009) 1.27
Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr (1999) 1.24
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis (2011) 1.15
High prevalence of human antibodies to recombinant Duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in nonimmune children. Infect Immun (2001) 1.13
Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur J Biochem (2001) 1.11
Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet (2000) 1.09
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol (1999) 1.08
Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput (1999) 1.08
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol (1993) 1.07
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther (1998) 1.07
Cyclophosphamide and related anticancer drugs. J Chromatogr B Biomed Sci Appl (2001) 1.06
High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant (1997) 1.04
Transport functions of the chick chorio-allantoic membrane. II. Active calcium transport, in vitro. Exp Cell Res (1969) 0.98
Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambaréné, Gabon. Parasitol Res (2002) 0.93
Total synthesis and biological evaluation of the nakijiquinones. J Am Chem Soc (2001) 0.92
Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study. Bone Marrow Transplant (2001) 0.89
CYP2C and IL-6 expression in breast cancer. Breast (2004) 0.88
Paraneoplastic limbic encephalitis in two teenage girls. Neuropediatrics (1998) 0.88
Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period. Klin Padiatr (2007) 0.88
Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism. Pediatr Res (1985) 0.86
Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme. Gene Ther (2000) 0.86
Gender difference in ifosfamide metabolism by human liver microsomes. Eur J Drug Metab Pharmacokinet (2001) 0.85
Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant (2012) 0.85
[The pharmacokinetics of bendamustine (Cytostasane) in humans]. Pharmazie (1985) 0.85
Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J (2005) 0.85
Lactic acidosis in Gabonese children with severe malaria is unrelated to dehydration. Clin Infect Dis (2006) 0.84
[Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma]. Klin Padiatr (2011) 0.84
Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: features of a classically conditioned response? Brain Behav Immun (2000) 0.83
Anti-angiogenic properties of a sulindac analogue. Br J Pharmacol (2007) 0.83
Cytokine-mediated regulation of granulocyte colony-stimulating factor production. Scand J Immunol (1999) 0.83
HPLC-methods for determination of lipoic acid and its reduced form in human plasma. Int J Clin Pharmacol Ther Toxicol (1992) 0.83
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr (2004) 0.83
General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases. Histol Histopathol (2012) 0.83
Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Padiatr (2009) 0.83
Interaction between histamine and adenosine in human cerebromicrovascular endothelial cells: modulation of second messengers. Metab Brain Dis (1994) 0.82
High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity. Klin Padiatr (2012) 0.82
[Improved treatment results in children with AML: Results of study AML-BFM 93]. Klin Padiatr (2001) 0.82
Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J Neurooncol (2001) 0.82
Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase. Chembiochem (2001) 0.82
Efficacy and outcome of intensive care in pediatric oncologic patients. Crit Care Med (2001) 0.82
[Umbilical venous catheters - analysis of malpositioning over a 10-year period]. Z Geburtshilfe Neonatol (2011) 0.81
Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin Padiatr (2004) 0.81
[Pharmacokinetics of bendamustin (Cytostasan) in B6D2F1-mice]. Pharmazie (1991) 0.81
[Inhibition of angiogenesis on the chicken chorioallantoic membrane by Ets 1 antisense oligodeoxyribonucleotides]. Verh Dtsch Ges Pathol (1999) 0.81
Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase. Bioorg Med Chem (2001) 0.80
Detection of antiphospholipid antibodies in children and adolescents. Pediatr Hematol Oncol (1998) 0.80
The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses. Blood (1997) 0.80
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes. Br J Cancer (2004) 0.80
Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour. Maligne Keimzelltumoren Study Group. Lancet (2000) 0.79
P450-expression in brain tumors. Oncol Res (1999) 0.79
Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies. Klin Padiatr (2003) 0.79
[MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia]. Rofo (2000) 0.79
Molecular mechanisms of hyperthermia- and cisplatin-induced cytotoxicity in T cell leukemia. Anticancer Res (2003) 0.79
[Immune tolerance induction with high-dose FVIII and pulsed intravenous immunoglobulin]. Hamostaseologie (2010) 0.79
Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis. Klin Padiatr (2011) 0.79
Inhibition of N-acetylglucosamine kinase and N-acetylmannosamine kinase by 3-O-methyl-N-acetyl-D-glucosamine in vitro. Eur J Biochem (1992) 0.79
TRAIL-induced cytotoxicity in a melphalan-resistant rhabdomyosarcoma cell line via activation of caspase-2. Anticancer Res (2006) 0.79
Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol (1997) 0.78
High-performance liquid chromatography methods for determination of lipoic and dihydrolipoic acid in human plasma. Methods Enzymol (1997) 0.78
[Obstructive icterus due to hemobilia]. Zentralbl Chir (1971) 0.78
Molecular mechanisms and gene regulation of melphalan- and hyperthermia-induced apoptosis in Ewing sarcoma cells. Anticancer Res (2008) 0.78
[Thrombosis in children with acute lymphoblastic leukemia treated with the COALL protocol]. Klin Padiatr (1994) 0.78
Pancreatoblastoma in children. Case report and review of the literature. Eur J Pediatr Surg (1996) 0.78
Na,K-ATPase in excitation-contraction coupling of vascular smooth muscle from cattle. Acta Biol Med Ger (1979) 0.78
Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma--a rationale for tailored supportive care. Support Care Cancer (2001) 0.78
Expression of mRNA for the proto-oncogene c-fos in rat basophilic leukaemia cells. Cell Signal (1997) 0.78
Osteosarcoma in a 16-year-old boy with Baller-Gerold syndrome. Clin Dysmorphol (1995) 0.78
Interleukin 10 induced c-fos expression in human B cells by activation of divergent protein kinases. Immunol Invest (1996) 0.78
The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials. Klin Padiatr (2013) 0.78
D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients. Int J Clin Pharmacol Ther (2005) 0.78
Transforming growth factor-beta1 suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes. Scand J Immunol (1999) 0.78
The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t. Leukemia (1998) 0.78
Regulation of interleukin-2 induced soluble Fas ligand release from human peripheral blood mononuclear cells. Immunol Invest (2004) 0.78
Haloperidol serum concentrations and D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Int Clin Psychopharmacol (1997) 0.77
Cerebromicrovascular endothelial permeability. In-vitro studies. Acta Neuropathol (1987) 0.77
Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand J Immunol (1995) 0.77
Cisplatin (CDDP)-induced radiation resistance is not associated with CDDP resistance in 86HG39 and A172 malignant glioma cells. Eur J Cancer (1999) 0.77